Physician profile
Ashley Doval
NPI 1306563549
$462.46
in general payments reported to CMS, 2019-2025
9 companies · $27.80 in 2025
The $27.80 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $370 · 2024: $64.48 · 2025: $27.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $449 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $448.57 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $236.63 | 2023-2024 | Evenity, Prolia |
| Radius Health, INC. | $52.07 | 2023 | Tymlos |
| Avanos Medical | $34.59 | 2023 | On-Q* Pump and Accessories |
| Boston Scientific Corporation | $27.80 | 2025 | General - Kidney Stone Disease |
| Bioventus LLC | $27.55 | 2023 | Exogen Ultrasound Bone Healing System |
| Alexion Pharmaceuticals, INC. | $22.41 | 2023 | Strensiq |
| Pacira Pharmaceuticals Incorporated | $21.42 | 2023 | Zilretta, Iovera, Exparel |
| Joint Active Systems, INC. | $20.51 | 2023 | |
| Smith+Nephew, INC. | $19.48 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Doval listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.